JPH04217650A - Production of acid addition salt of delta-amino-levulinic acid - Google Patents
Production of acid addition salt of delta-amino-levulinic acidInfo
- Publication number
- JPH04217650A JPH04217650A JP3022372A JP2237291A JPH04217650A JP H04217650 A JPH04217650 A JP H04217650A JP 3022372 A JP3022372 A JP 3022372A JP 2237291 A JP2237291 A JP 2237291A JP H04217650 A JPH04217650 A JP H04217650A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- compound
- addition salt
- group
- delta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 title claims abstract description 35
- 239000002253 acid Substances 0.000 title claims abstract description 34
- 150000003839 salts Chemical class 0.000 title claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 title claims description 14
- 150000001875 compounds Chemical class 0.000 claims abstract description 15
- 125000006239 protecting group Chemical group 0.000 claims abstract description 14
- 238000006243 chemical reaction Methods 0.000 claims abstract description 13
- 125000003277 amino group Chemical group 0.000 claims abstract description 10
- YNOGYQAEJGADFJ-UHFFFAOYSA-N oxolan-2-ylmethanamine Chemical compound NCC1CCCO1 YNOGYQAEJGADFJ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 5
- 150000007522 mineralic acids Chemical group 0.000 claims description 4
- 150000007524 organic acids Chemical group 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 229960002749 aminolevulinic acid Drugs 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 8
- ZNBXDWLLIYOFNP-UHFFFAOYSA-N 2-(oxolan-2-ylmethyl)isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC1CCCO1 ZNBXDWLLIYOFNP-UHFFFAOYSA-N 0.000 abstract description 6
- LAHGDKJZEHFOAZ-UHFFFAOYSA-N 2-[(5-oxooxolan-2-yl)methyl]isoindole-1,3-dione Chemical compound O1C(=O)CCC1CN1C(=O)C2=CC=CC=C2C1=O LAHGDKJZEHFOAZ-UHFFFAOYSA-N 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 abstract description 2
- 239000003513 alkali Substances 0.000 abstract description 2
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 abstract description 2
- 230000003472 neutralizing effect Effects 0.000 abstract description 2
- IROQTJRDINLHEO-UHFFFAOYSA-N 5-(1,3-dioxoisoindol-2-yl)-4-oxopentanoic acid Chemical compound C1=CC=C2C(=O)N(CC(=O)CCC(=O)O)C(=O)C2=C1 IROQTJRDINLHEO-UHFFFAOYSA-N 0.000 abstract 4
- 125000001557 phthalyl group Chemical group C(=O)(O)C1=C(C(=O)*)C=CC=C1 0.000 abstract 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 34
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 239000002904 solvent Substances 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 238000005160 1H NMR spectroscopy Methods 0.000 description 10
- 229940040102 levulinic acid Drugs 0.000 description 10
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 8
- 229950010481 5-aminolevulinic acid hydrochloride Drugs 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 239000003960 organic solvent Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- BIXNGBXQRRXPLM-UHFFFAOYSA-K ruthenium(3+);trichloride;hydrate Chemical compound O.Cl[Ru](Cl)Cl BIXNGBXQRRXPLM-UHFFFAOYSA-K 0.000 description 4
- WOCIAKWEIIZHES-UHFFFAOYSA-N ruthenium(iv) oxide Chemical compound O=[Ru]=O WOCIAKWEIIZHES-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N DMSO-d6 Substances [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000007806 chemical reaction intermediate Substances 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- GAEKPEKOJKCEMS-UHFFFAOYSA-N gamma-valerolactone Chemical compound CC1CCC(=O)O1 GAEKPEKOJKCEMS-UHFFFAOYSA-N 0.000 description 3
- PUWUDJOAVMKLBK-UHFFFAOYSA-N n-(oxolan-2-ylmethyl)benzamide Chemical compound C=1C=CC=CC=1C(=O)NCC1CCCO1 PUWUDJOAVMKLBK-UHFFFAOYSA-N 0.000 description 3
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 2
- 239000002920 hazardous waste Substances 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 229910001925 ruthenium oxide Inorganic materials 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- -1 δ-chlorolevulinic acid ester Chemical class 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- YHUFRVYVNKGICT-UHFFFAOYSA-N 4,5-dioxopentanoic acid Chemical compound OC(=O)CCC(=O)C=O YHUFRVYVNKGICT-UHFFFAOYSA-N 0.000 description 1
- XTIKIVWSYBVJJK-UHFFFAOYSA-N 5-bromo-4-oxopentanoic acid Chemical compound OC(=O)CCC(=O)CBr XTIKIVWSYBVJJK-UHFFFAOYSA-N 0.000 description 1
- BCEIUDAMUFAQMG-UHFFFAOYSA-M CC(C)(C)O[Cr](O)(=O)=O Chemical compound CC(C)(C)O[Cr](O)(=O)=O BCEIUDAMUFAQMG-UHFFFAOYSA-M 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229940117975 chromium trioxide Drugs 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229910001927 ruthenium tetroxide Inorganic materials 0.000 description 1
- YBCAZPLXEGKKFM-UHFFFAOYSA-K ruthenium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Ru+3] YBCAZPLXEGKKFM-UHFFFAOYSA-K 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000005891 transamination reaction Methods 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、δ−アミノレブリン酸
の酸付加塩の製造方法に関する。δ−アミノレブリン酸
の酸付加塩は、中和によりδ−アミノレブリン酸へ容易
に変換される。δ−アミノレブリン酸は化学的に不安定
であり、通常、酸付加塩の形で保存・流通に供される。FIELD OF THE INVENTION The present invention relates to a method for producing acid addition salts of δ-aminolevulinic acid. Acid addition salts of δ-aminolevulinic acid are easily converted to δ-aminolevulinic acid by neutralization. δ-Aminolevulinic acid is chemically unstable and is usually stored and distributed in the form of an acid addition salt.
【0002】0002
【従来の技術】δ−アミノレブリン酸は、ビタミンB1
2、ヘム及び葉緑素の先駆物質として知られている。
また、δ−アミノレブリン酸は、米国イリノイ大学のリ
バイツらにより選択的除草作用のあることも報告されて
いる。(Enzyme Microb. Techno
l.,Vol.6 ,P390(1984))かかるδ
−アミノレブリン酸の合成中間体であるδ−アミノレブ
リン酸の酸付加塩の製造方法としては、従来よりいくつ
かの方法が知られている。例えば、ピシャらはδ−クロ
ロレブリン酸エステルまたはδ−レブリン酸エステルを
δ−フタルイミド誘導体にかえてδ−アミノレブリン酸
の酸付加塩に誘導する方法を報告している(Bull.
Soc. Chim.Fr.,1750(1956)
)。[Prior art] δ-aminolevulinic acid is a vitamin B1
2. Known as a precursor of heme and chlorophyll. Furthermore, it has been reported that δ-aminolevulinic acid has a selective herbicidal effect by Rivaiz et al. of the University of Illinois in the United States. (Enzyme Microb. Techno
l. , Vol. 6, P390 (1984))
Several methods are conventionally known for producing acid addition salts of δ-aminolevulinic acid, which is a synthetic intermediate of -aminolevulinic acid. For example, Pisha et al. have reported a method for converting δ-chlorolevulinic acid ester or δ-levulinic acid ester into a δ-phthalimide derivative to convert it into an acid addition salt of δ-aminolevulinic acid (Bull.
Soc. Chim. Fr. , 1750 (1956)
).
【0003】また、ビーレンらは、δ−ブロモレブリン
酸から得られる4,5−ジオキソバレイン酸を用いて、
非酵素的トランスアミノ化反応を行うことによりδ−ア
ミノレブリン酸の酸付加塩を合成する方法を報告してい
る(Phytochemistry,Vol.18,4
41(1979))。[0003] Also, Bielen et al. used 4,5-dioxovaleric acid obtained from δ-bromolevulinic acid,
reported a method for synthesizing acid addition salts of δ-aminolevulinic acid by performing a non-enzymatic transamination reaction (Phytochemistry, Vol. 18, 4).
41 (1979)).
【0004】さらに、プファルツらは、ケトニトリル化
合物を亜鉛と酢酸で還元してδ−アミノレブリン酸の酸
付加塩を合成する方法を報告している(Tetrahe
doron Lett.,Vol.25, No.28
,2977(1984)) 。Furthermore, Palatinate et al. reported a method for synthesizing an acid addition salt of δ-aminolevulinic acid by reducing a ketonitrile compound with zinc and acetic acid (Tetrahe et al.
doron Lett. , Vol. 25, No. 28
, 2977 (1984)).
【0005】[0005]
【発明が解決しようとする課題】しかしながら、従来の
δ−アミノレブリン酸の酸付加塩の製造方法は、いずれ
もδ−アミノレブリン酸を工業的に効率よく生産するこ
とができない。また、従来の製造方法では、原料が高価
であったり、製造工程が煩雑であったりまた有害廃棄物
が生じる等の理由から製造コストが高くなる問題がある
。[Problems to be Solved by the Invention] However, none of the conventional methods for producing acid addition salts of δ-aminolevulinic acid is capable of industrially producing δ-aminolevulinic acid efficiently. In addition, conventional manufacturing methods have problems such as high manufacturing costs due to expensive raw materials, complicated manufacturing processes, and generation of hazardous waste.
【0006】本発明は、かかる点に鑑みてなされたもの
であり、入手し易くかつ安価な原料から収率良くδ−ア
ミノレブリン酸の酸付加塩を工業的に生産できるδ−ア
ミノレブリン酸の酸付加塩の製造方法を提供するもので
ある。The present invention has been made in view of the above points, and is an acid addition method of δ-aminolevulinic acid that can industrially produce acid addition salts of δ-aminolevulinic acid in good yield from readily available and inexpensive raw materials. A method for producing salt is provided.
【0007】[0007]
【発明が解決しようとする課題】本発明者らは、上記の
目的を達成するために鋭意研究を重ねた結果、入手し易
くしかも安価なテトラヒドロフルフリルアミンを出発原
料として簡単な工程によりδ−アミノレブリン酸の酸付
加塩を得られることを見いだした。[Problems to be Solved by the Invention] As a result of intensive research to achieve the above object, the present inventors have devised a method for producing δ-aminolevulin by a simple process using easily available and inexpensive tetrahydrofurfurylamine as a starting material. It has been found that acid addition salts of acids can be obtained.
【0008】すなわち、本発明は、化2に示す反応式
(1)で示されるように、一般式(IV)で示されるテ
トラヒドロフルフリルアミン(IV)のアミノ基に該ア
ミノ基を保護する保護基を導入して一般式(III)
で示される化合物(III) を得る工程と、得られた
化合物(III)の1位及び4位の炭素を酸化すること
により一般式(II)で示される化合物(II)を得る
工程と、得られた化合物(II)の保護基を酸で脱保護
する工程とを具備することを特徴とする一般式(I)で
示されるδ−アミノレブリン酸の酸付加塩の製造方法で
ある。That is, the present invention is based on the reaction formula shown in Chemical formula 2.
As shown in (1), a protecting group for protecting the amino group is introduced into the amino group of tetrahydrofurfurylamine (IV) shown by the general formula (IV), and the general formula (III) is obtained.
A step of obtaining a compound (III) represented by the formula (III), a step of obtaining a compound (II) represented by the general formula (II) by oxidizing the carbons at the 1st and 4th positions of the obtained compound (III), A method for producing an acid addition salt of δ-aminolevulinic acid represented by the general formula (I), comprising the step of deprotecting the protecting group of the compound (II) obtained by using an acid.
【0009】[0009]
【化2】[Chemical 2]
【0010】(式中、R,R′は、一般的なアミノ基の
保護基または水素原子であり、少なくとも一方は一般的
なアミノ基の保護基である。また、R,R′の両方が前
記保護基である場合に、R,R′は互いに結合して環状
になっていてもよい。また、式中Xは、一価の有機酸根
または無機酸根である。)以下、本発明のδ−アミノレ
ブリン酸の酸付加塩の製造方法を更に詳細に説明する。(In the formula, R and R' are a general amino group-protecting group or a hydrogen atom, and at least one is a general amino group-protecting group. Also, both R and R' are In the case of the above-mentioned protecting group, R and R' may be bonded to each other to form a ring. In the formula, X is a monovalent organic acid group or an inorganic acid group.) Hereinafter, δ of the present invention - The method for producing an acid addition salt of aminolevulinic acid will be explained in more detail.
【0011】本発明では、安価で入手し易いテトラヒド
ロフルフリルアミン(IV)を出発物質として用いる。In the present invention, tetrahydrofurfurylamine (IV), which is inexpensive and easily available, is used as a starting material.
【0012】また、工程(a)のアミノ基の保護基とし
ては、一般的にアミノ基の保護基として用いることがで
きるものであれば特に限定されず、例えば、アシル基、
シリル基等を用いることができる。アミノ基の保護基R
,R′は、その両方が上述のような保護基であっても、
一方が該保護基であって他方が水素原子であっても良い
。また、フタルイミド等のように、R,R′が互いに結
合して環状になっている保護基であってもよい。The protecting group for the amino group in step (a) is not particularly limited as long as it can generally be used as a protecting group for the amino group. For example, an acyl group,
A silyl group or the like can be used. Protecting group R for amino group
, R' are both protecting groups as described above,
One may be the protecting group and the other may be a hydrogen atom. It may also be a protecting group in which R and R' are bonded to each other to form a cyclic structure, such as phthalimide.
【0013】工程(b)における1位及び4位の炭素の
酸化は、ルテニウムオキシドによる酸化反応若しくはク
ロム酸系酸化剤による酸化反応により行うことができる
。[0013] The oxidation of carbons at the 1st and 4th positions in step (b) can be carried out by an oxidation reaction using ruthenium oxide or an oxidation reaction using a chromic acid-based oxidizing agent.
【0014】ルテニウムオキシドによる酸化反応は、例
えば、適当な溶媒中で、共酸化剤の過ヨウ素酸ナトリウ
ム、過ヨウ素酸カリウム、次亜塩素酸ナトリウム、臭素
酸ナトリウム等と共に四酸化ルテニウム、二酸化ルテニ
ウムまたは三塩化ルテニウム触媒を用いて一晩撹拌して
行われる。この適当な溶媒としては、例えば、四塩化炭
素、アセトニトリル及び水等の混合溶媒であるが、特に
限定されるものではない。The oxidation reaction using ruthenium oxide can be carried out, for example, by using ruthenium tetroxide, ruthenium dioxide or It is carried out using a ruthenium trichloride catalyst and stirring overnight. This suitable solvent is, for example, a mixed solvent of carbon tetrachloride, acetonitrile, water, etc., but is not particularly limited.
【0015】一方、クロム酸系酸化剤による酸化反応は
、適当な溶媒中、例えば、アセトン等の有機溶媒中で、
三酸化クロム、クロム酸t−ブチル等を用いて行われる
。On the other hand, the oxidation reaction using a chromic acid-based oxidizing agent is carried out in an appropriate solvent, for example, an organic solvent such as acetone.
This is carried out using chromium trioxide, t-butyl chromate, etc.
【0016】このような酸化反応は、化3に示される一
般式(V)のような反応中間体(V)を経て進行する。
反応中間体(V)は、実際反応途中に単離することも可
能である。また、反応中間体(V)を用いて工程(b)
と同様の酸化反応を行うことにより化合物(II)を得
ることができる。[0016] Such an oxidation reaction proceeds via a reaction intermediate (V) such as the general formula (V) shown in Chemical Formula 3. The reaction intermediate (V) can actually be isolated during the reaction. In addition, step (b) using the reaction intermediate (V)
Compound (II) can be obtained by carrying out an oxidation reaction similar to the above.
【0017】[0017]
【化3】[Chemical formula 3]
【0018】工程(c)のアミノ基の保護基の脱保護反
応は、酸を用いて適当な溶媒中で行われる。この脱保護
反応に使用される酸は、δ−アミノレブリン酸のアミノ
基と酸付加塩を形成する有機酸または無機酸である。こ
のような有機酸としては、例えば、酢酸、トリフルオロ
酢酸、パラトルエンスルホン酸等が挙げられる。また、
無機酸としては、塩酸、硫酸、硝酸等を例示することが
できる。The deprotection reaction of the protecting group for the amino group in step (c) is carried out using an acid in a suitable solvent. The acid used in this deprotection reaction is an organic or inorganic acid that forms an acid addition salt with the amino group of δ-aminolevulinic acid. Examples of such organic acids include acetic acid, trifluoroacetic acid, para-toluenesulfonic acid, and the like. Also,
Examples of inorganic acids include hydrochloric acid, sulfuric acid, and nitric acid.
【0019】また、適当な溶媒は、例えば、水やジオキ
サン等であるが、特に限定されるものではない。[0019] Suitable solvents include, for example, water and dioxane, but are not particularly limited.
【0020】このようにして得られたδ−アミノレブリ
ン酸の酸付加塩(I)を、例えば、特開平2−7684
1号公報に開示されているように、δ−アミノレブリン
酸の酸付加塩(I)を水酸化ナトリウム等のアルカリで
中和することによりδ−アミノレブリン酸が得られる。The acid addition salt (I) of δ-aminolevulinic acid thus obtained is disclosed in, for example, JP-A-2-7684.
As disclosed in Publication No. 1, δ-aminolevulinic acid can be obtained by neutralizing the acid addition salt (I) of δ-aminolevulinic acid with an alkali such as sodium hydroxide.
【0021】[0021]
【実施例】以下、本発明の実施例について詳細に説明す
る。[Examples] Examples of the present invention will be described in detail below.
【0022】実施例1
(A)N−テトラヒドロフルフリルフタルイミドの製造
無水フタル酸19.8g (134 mmol)をクロ
ロホルム500 mlに溶解する。この溶液にテトラヒ
ドロフルフリルアミン10g (99mmol)を撹拌
しながら加えた。次に、混合溶液を一晩加熱還流しなが
ら生じる水を留去した。放冷後、反応溶液を飽和重曹水
300ml中にあけて有機溶媒層を分離した。水層を
クロロホルムで2度抽出した後、抽出液を先に分離した
有機溶媒層と合わせた。Example 1 (A) Preparation of N-tetrahydrofurfuryl phthalimide 19.8 g (134 mmol) of phthalic anhydride is dissolved in 500 ml of chloroform. 10 g (99 mmol) of tetrahydrofurfurylamine was added to this solution with stirring. Next, the mixed solution was heated under reflux overnight, and the water produced was distilled off. After cooling, the reaction solution was poured into 300 ml of saturated sodium bicarbonate solution to separate the organic solvent layer. After the aqueous layer was extracted twice with chloroform, the extract was combined with the previously separated organic solvent layer.
【0023】次に、有機溶媒層を重曹水及び水で洗浄し
た後、無水硫酸マグネシウムで乾燥した。減圧下溶媒を
留去した後に、得られた粗生成物をヘキサン:塩化メチ
レン混合溶媒により再結晶してN−テトラヒドロフルフ
リルフタルイミドを得た。Next, the organic solvent layer was washed with aqueous sodium bicarbonate and water, and then dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the obtained crude product was recrystallized from a hexane:methylene chloride mixed solvent to obtain N-tetrahydrofurfuryl phthalimide.
【0024】
N−テトラヒドロフルフリルフタルイミド収 量:2
1.8g (収率95.2%)融 点:86.5〜
87.5℃
1H−NMR(CDCL3 ):δ7.9− 7.8
(m,aromatic−H),7.75−7.65(
m,aromatic−H), 4.3−4.2(1H
,m),4.0−3.6(4H,m),2.1−1.8
(3H,m),1.75−1.6 (1H,m) 。N-tetrahydrofurfuryl phthalimide yield: 2
1.8g (Yield 95.2%) Melting point: 86.5~
87.5°C 1H-NMR (CDCL3): δ7.9-7.8
(m, aromatic-H), 7.75-7.65 (
m, aromatic-H), 4.3-4.2 (1H
, m), 4.0-3.6 (4H, m), 2.1-1.8
(3H, m), 1.75-1.6 (1H, m).
【0025】
(B)5−フタルイミドペンタン−4−オリド及び5−
フタルイミドレブリン酸の製造
工程(A)で得たN−テトラヒドロフルフリルフタルイ
ミド5.0 g (22mmol)の四塩化炭素25m
l・アセトニトリル25ml・水30mlの二相系混合
溶液に、粉末状過ヨウ素酸ナトリウム19g (87m
mol)、塩化ルテニウム水和物0.10g (2.2
mol%)を加え、周囲温度で一晩激しく撹拌した。反
応終了後、不溶物を濾別した後、減圧下溶媒を留去した
。得られた残留物をクロロホルム・1N塩酸水溶液に溶
解してクロロホルムで抽出した。この有機溶媒層を無水
硫酸マグネシウムで乾燥し、減圧下溶媒を留去した。得
られた残留物を、溶出液としてクロロホルム:メタノー
ル=95:5v/v を用いてシリカゲル上でカラムク
ロマトグラフを行い、5−フタルイミドペンタン−4−
オリドを得た。さらに、クロロホルム:メタノール:ギ
酸=95:4:1v/v を用いてカラムクロマトグラ
フを行い、5−フタルイミドレブリン酸を得た。(B) 5-phthalimidopentane-4-olide and 5-
5.0 g (22 mmol) of N-tetrahydrofurfuryl phthalimide obtained in step (A) for producing phthalimide levulinic acid and 25 m of carbon tetrachloride.
19 g of powdered sodium periodate (87 m
mol), Ruthenium chloride hydrate 0.10g (2.2
mol%) and stirred vigorously at ambient temperature overnight. After the reaction was completed, insoluble matter was filtered off, and the solvent was distilled off under reduced pressure. The obtained residue was dissolved in chloroform/1N aqueous hydrochloric acid solution and extracted with chloroform. This organic solvent layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was subjected to column chromatography on silica gel using chloroform:methanol=95:5v/v as an eluent to obtain 5-phthalimidopentane-4-
I got Orid. Furthermore, column chromatography was performed using chloroform:methanol:formic acid=95:4:1v/v to obtain 5-phthalimide revulinic acid.
【0026】
5−フタルイミドペンタン−4−オリド収 量:1.
5 g (収率28%)融 点:170 〜171
℃
1H−NMR(CDCL3 ):δ7.91−7.8
3(2H,m,aromatic−H),7.78−7
.72 (2H,m,aromatic−H) ,4.
87(1H,dq,J=5.3&7.1Hz,H−4)
,4.02(1H,dd,J=14.2,7.7Hz,
H−5),3.84(1H,dd,J=14.2,5.
2Hz,H−5),2.71 − 2.49(2H,m
,H−2),2.46−2.34(1H,m,H−3)
,2.13−2.03(1H,m,H−3) 。5-phthalimidopentane-4-olide yield: 1.
5 g (Yield 28%) Melting point: 170-171
°C 1H-NMR (CDCL3): δ7.91-7.8
3 (2H, m, aromatic-H), 7.78-7
.. 72 (2H, m, aromatic-H), 4.
87 (1H, dq, J = 5.3 & 7.1Hz, H-4)
, 4.02 (1H, dd, J=14.2, 7.7Hz,
H-5), 3.84 (1H, dd, J=14.2, 5.
2Hz, H-5), 2.71 - 2.49 (2H, m
, H-2), 2.46-2.34 (1H, m, H-3)
, 2.13-2.03 (1H, m, H-3).
【0027】
5−フタルイミドレブリン酸
収 量:2.1 g (収率37%)融 点:16
0 〜162 ℃
1H−NMR(CDCL3 −DMSO−d6 ):
δ7.88−7.83 (m,aromatic−H)
,7.78−7.73(m,aromatic−H),
4.57 (s,H−5),2.85(t,J=6.6
Hz,H−3),2.64(t,J=6.6Hz, H
−2)。5-phthalimide revulinic acid yield: 2.1 g (yield 37%) melting point: 16
0-162°C 1H-NMR (CDCL3-DMSO-d6):
δ7.88-7.83 (m, aromatic-H)
, 7.78-7.73 (m, aromatic-H),
4.57 (s, H-5), 2.85 (t, J=6.6
Hz, H-3), 2.64 (t, J=6.6Hz, H
-2).
【0028】
(C)5−フタルイミドレブリン酸
工程(B)で得た5−フタルイミドペンタン−4−オリ
ド0.30g (1.2mmol) の四塩化炭素 2
.0ml・アセトニトリル10ml・水 3.0mlの
二相系混合溶液に、粉末状過ヨウ素酸ナトリウム 2.
5g (12mmol) 、塩化ルテニウム水和物90
mg(30 mol%)を加え、50℃で24時間厳し
く撹拌した。反応終了後、減圧下溶媒を留去した。(C) 5-phthalimidopentane-4-olide obtained in step (B) 0.30 g (1.2 mmol) of carbon tetrachloride 2
.. Add powdered sodium periodate to a two-phase mixed solution of 0 ml, acetonitrile 10 ml, and water 3.0 ml.
5g (12mmol), Ruthenium chloride hydrate 90
mg (30 mol%) and stirred vigorously at 50°C for 24 hours. After the reaction was completed, the solvent was distilled off under reduced pressure.
【0029】次に、得られた残留物をクロロホルム・1
N塩酸水溶液に溶解し、クロロホルムで抽出した。有機
溶媒層を無水硫酸マグネシウムで乾燥し、減圧下溶媒を
留去した。得られた残留物をシリカゲルカラムクロマト
グラフ(クロロホルム:メタノール:ギ酸=95:4:
1v/v )で精製し、5−フタルイミドレブリン酸を
得た。Next, the obtained residue was diluted with chloroform.
It was dissolved in an aqueous N hydrochloric acid solution and extracted with chloroform. The organic solvent layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was subjected to silica gel column chromatography (chloroform: methanol: formic acid = 95:4:
1v/v) to obtain 5-phthalimide revulinic acid.
【0030】
5−フタルイミドレブリン酸
収 量:32mg(収率10%)
融 点:160 〜162 ℃
1H−NMR(CDCL3 −DMSO−d6 ):
δ7.88−7.83 (m,aromatic−H)
,7.78−7.73(m,aromatic−H),
4.57(s,H−5),2.85(t,J=6.6H
z,H−3),2.64(t,J=6.6 Hz,H−
2) 。5-phthalimide revulinic acid yield: 32 mg (yield 10%) Melting point: 160-162°C 1H-NMR (CDCL3-DMSO-d6):
δ7.88-7.83 (m, aromatic-H)
, 7.78-7.73 (m, aromatic-H),
4.57 (s, H-5), 2.85 (t, J=6.6H
z, H-3), 2.64 (t, J=6.6 Hz, H-
2).
【0031】
(D)5−アミノレブリン酸塩酸塩の製造工程(B),
(C)で得た5−フタルイミドレブリン酸2.1 g
(8.0mmol )を6N塩酸水溶液 100mlに
懸濁し、8時間加熱還流した。反応終了後、反応溶液を
周囲温度まで冷却した。次に、晶出した結晶を濾別した
後減圧下溶媒を留去した。さらに得られた残留物を、エ
タノール−水より再結晶化して5−アミノレブリン酸塩
酸塩を得た。(D) 5-aminolevulinic acid hydrochloride production step (B),
2.1 g of 5-phthalimide levulinic acid obtained in (C)
(8.0 mmol) was suspended in 100 ml of 6N aqueous hydrochloric acid solution and heated under reflux for 8 hours. After the reaction was completed, the reaction solution was cooled to ambient temperature. Next, the crystals that had crystallized were filtered off, and the solvent was then distilled off under reduced pressure. Furthermore, the obtained residue was recrystallized from ethanol-water to obtain 5-aminolevulinic acid hydrochloride.
【0032】
5−アミノレブリン酸塩酸塩
収 量:0.861 g (収率63.8%)融
点:142 〜 145℃
(文献値149 〜151 ℃)
1H−NMR(D2 O):δ4.07(s,H−5
),2.84(t,J=6.3Hz,H−3),2.6
6(t,J=6.2Hz,H−2) 。5-Aminolevulinic acid hydrochloride Yield: 0.861 g (yield 63.8%)
Point: 142 to 145°C (Literature value 149 to 151°C) 1H-NMR (D2O): δ4.07 (s, H-5
), 2.84 (t, J=6.3Hz, H-3), 2.6
6 (t, J=6.2Hz, H-2).
【0033】実施例2
実施例1の工程(A)で得たN−テトラヒドロフルフリ
ルフタルイミド0.30g (1.3 mmol)の四
塩化炭素 2ml・アセトニトリル10ml・水 3m
lの二相系混合溶液に、粉末状過ヨウ素酸ナトリウム1
.7 g (7.8mmol) 、塩化ルテニウム水和
物 8.0mg(2.2mol%)を加え、80℃で一
晩厳しく撹拌した。反応終了後、減圧下溶媒を留去した
。得られた残留物をクロロホルム・1N塩酸水溶液に溶
解し、クロロホルムで抽出、有機溶媒層を無水硫酸マグ
ネシウムで乾燥し、減圧下溶媒を留去した。得られた残
留物をシリカゲルカラムクロマトグラフ(クロロホルム
:メタノール:ギ酸=95:4:1v/v )で精製し
、実施例1のように5−フタルイミドプロパン−4−オ
リドを生成することなく5−フタルイミドレブリン酸を
得た。Example 2 0.30 g (1.3 mmol) of N-tetrahydrofurfuryl phthalimide obtained in step (A) of Example 1, 2 ml of carbon tetrachloride, 10 ml of acetonitrile, and 3 m of water
Add 1 part of powdered sodium periodate to 1 part of the two-phase mixed solution.
.. 7 g (7.8 mmol) and 8.0 mg (2.2 mol%) of ruthenium chloride hydrate were added, and the mixture was vigorously stirred at 80° C. overnight. After the reaction was completed, the solvent was distilled off under reduced pressure. The obtained residue was dissolved in chloroform/1N aqueous hydrochloric acid solution, extracted with chloroform, the organic solvent layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (chloroform:methanol:formic acid = 95:4:1v/v), and as in Example 1, 5-phthalimidopropane-4-olide was not produced. Phthalimide levulinic acid was obtained.
【0034】
5−フタルイミドレブリン酸
収 量:0.20g (収率59%)融 点: 1
60〜 162℃
1H−NMR(CDCL3 −DMSO−d6 ):
δ7.88−7.83 (m,aromatic−H)
,7.78−7.73(m,aromatic−H),
4.57(s,H−5),2.85(t,J=6.6H
z,H−3),2.64(t,J=6.6Hz,H−2
)。5-phthalimide levulinic acid yield: 0.20 g (yield 59%) melting point: 1
60-162°C 1H-NMR (CDCL3-DMSO-d6):
δ7.88-7.83 (m, aromatic-H)
, 7.78-7.73 (m, aromatic-H),
4.57 (s, H-5), 2.85 (t, J=6.6H
z, H-3), 2.64 (t, J=6.6Hz, H-2
).
【0035】得られた5−フタルイミドレブリン酸を、
実施例1の工程(D)と同様に脱保護して5−アミノレ
ブリン酸塩酸塩を得た。The obtained 5-phthalimide revulinic acid,
Deprotection was performed in the same manner as in step (D) of Example 1 to obtain 5-aminolevulinic acid hydrochloride.
【0036】実施例3
(A)N−ベンゾイルテトラヒドロフルフリルアミドの
製造
テトラヒドロフルフリルアミン10ml(97mmol
) 、および、トリエチルアミン15ml(107mm
ol)のベンゼン溶液に、無水条件下、 0℃で、塩化
ベンゾイル 11ml (97mmol) をゆっくり
と滴下した。滴下が終了した後、この溶液を周囲温度で
一晩撹拌し、反応終了後、減圧下で溶媒を留去した。得
られた残留物をn−ヘキサン−酢酸エチル混合溶液から
再結晶して、N−ベンゾイルテトラヒドロフルフリルア
ミドを得た。Example 3 (A) Preparation of N-benzoyltetrahydrofurfurylamide Tetrahydrofurfurylamine 10ml (97mmol)
), and 15 ml of triethylamine (107 mm
11 ml (97 mmol) of benzoyl chloride was slowly added dropwise to the benzene solution of ol) at 0°C under anhydrous conditions. After the addition was complete, the solution was stirred at ambient temperature overnight, and after the reaction was complete, the solvent was distilled off under reduced pressure. The obtained residue was recrystallized from a mixed solution of n-hexane and ethyl acetate to obtain N-benzoyltetrahydrofurfurylamide.
【0037】
N−ベンゾイルテトラヒドロフルフリルアミド収 量
:16g (収率77%)
融 点: 93〜94℃
1H−NMR(CDCl3 ):δ7.80−7.8
6 (2H,m,aromatic−H),7.52−
7.38(2H,m,aromatic−H) ,6.
61 (1H,br,NH), 4.07(1H,dq
,J=7.1 ,3.3Hz,H−4),3.93−3
.72(3H,m,H−1,H−5),3.35(1H
,ddd,J=13.4,7.7,5.3Hz,H−5
),2.09−1.86(3H,m,H−2,H−3)
,1.68−1.54(1H,m,H−3) 。N-benzoyltetrahydrofurfurylamide Yield: 16 g (yield 77%) Melting point: 93-94°C 1H-NMR (CDCl3): δ7.80-7.8
6 (2H, m, aromatic-H), 7.52-
7.38 (2H, m, aromatic-H), 6.
61 (1H, br, NH), 4.07 (1H, dq
, J=7.1, 3.3Hz, H-4), 3.93-3
.. 72 (3H, m, H-1, H-5), 3.35 (1H
, ddd, J=13.4, 7.7, 5.3Hz, H-5
), 2.09-1.86 (3H, m, H-2, H-3)
, 1.68-1.54 (1H, m, H-3).
【0038】
(B)5−ベンゾイルアミドペンタン−4−オリドおよ
び5−ベンゾイルアミドレブリン酸の製造N−ベンゾイ
ルテトラヒドロフルフリルアミド0.3 g (1.4
6mmol)の四塩化炭素 2ml・アセトニトリル1
0ml・水 3mlの二相系混合溶液に、粉末状過ヨウ
素酸ナトリウム 1.9 g(8.8 mmol)、塩
化ルテニウム水和物 8 mg ( 2.2mol%)
を加え、周囲温度で一晩激しく撹拌した。反応が終了し
た後、不溶物を濾別し、減圧下で溶媒を留去した。得ら
れた残留物をクロロホルム・1N塩酸水溶液に溶解し、
クロロホルムで抽出した。この抽出液を無水硫酸マグネ
シウムで乾燥し、減圧下でクロロホルムを留去した。得
られた残留物を、シリカゲルを用いたカラムクロマトグ
ラフを行った。溶出液としてクロロホルムおよびメタノ
ールを30:1V/V の割合で混合した混合溶液を用
いることにより、5−ベンゾイルアミドペンタン−4−
オリドが溶出した。さらに、クロロホルム、メタノール
およびギ酸を18:1:1V/V の割合で混合した混
合液により、5−ベンゾイルアミドレブリン酸が溶出し
た。(B) Preparation of 5-benzoylamide pentan-4-olide and 5-benzoylamide levulinic acid N-benzoyltetrahydrofurfurylamide 0.3 g (1.4
6 mmol) carbon tetrachloride 2 ml acetonitrile 1
In a two-phase mixed solution of 0 ml and 3 ml of water, 1.9 g (8.8 mmol) of powdered sodium periodate and 8 mg (2.2 mol%) of ruthenium chloride hydrate were added.
was added and stirred vigorously at ambient temperature overnight. After the reaction was completed, insoluble matter was filtered off, and the solvent was distilled off under reduced pressure. The obtained residue was dissolved in chloroform/1N hydrochloric acid aqueous solution,
Extracted with chloroform. This extract was dried over anhydrous magnesium sulfate, and chloroform was distilled off under reduced pressure. The obtained residue was subjected to column chromatography using silica gel. By using a mixed solution of chloroform and methanol at a ratio of 30:1 V/V as an eluent, 5-benzoylamide pentane-4
Olide was eluted. Furthermore, 5-benzoylamide levulinic acid was eluted with a mixture of chloroform, methanol, and formic acid in a ratio of 18:1:1 V/V.
【0039】
5−ベンゾイルアミドペンタン−4−オリド収 量:
0.076 g (収率24.0%)融 点: 12
9〜 130℃
1H−NMR(CDCl3 ):δ7.83−7.7
7 (2H,m,aromatic−H),7.54−
7.37(3H,m,aromatic−H) ,7.
02 (1H,br,NH), 4.73(1H,dq
,J=7.3,3.4Hz,H−4),3.90(1H
,ddd,J=14.5,6.6,3.2Hz,H−5
),3.54(1H,ddd,J=14.5,7.0,
5.6Hz,H−5) 2.59−2.51(2H,m
,H−2),2.41−2.28(1H,m,H−3)
,2.09−1.94(1H,m,H−3)。5-benzoylamide pentane-4-olide yield:
0.076 g (yield 24.0%) Melting point: 12
9-130°C 1H-NMR (CDCl3): δ7.83-7.7
7 (2H, m, aromatic-H), 7.54-
7.37 (3H, m, aromatic-H), 7.
02 (1H, br, NH), 4.73 (1H, dq
, J=7.3, 3.4Hz, H-4), 3.90 (1H
, ddd, J=14.5, 6.6, 3.2Hz, H-5
), 3.54 (1H, ddd, J=14.5, 7.0,
5.6Hz, H-5) 2.59-2.51(2H, m
, H-2), 2.41-2.28 (1H, m, H-3)
, 2.09-1.94 (1H, m, H-3).
【0040】
5−ベンゾイルアミドレブリン酸
収 率:0.075 g (収率21.8%)融
点:120 〜 122℃
1H−NMR(CD3 OD):δ7.85 (2H
,d,J=7.1Hz,aromatic−H),7.
55(1H,t,J=7.2Hz,aromatic−
H) ,7.46(2H,t,J=7.3Hz,aro
matic−H), 4.26 (2H,s,H−5)
,2.80(3H,t,J=6.3Hz,H−3),2
.61(2H,t,J=6.4Hz,H−2) 。5-benzoylamide levulinic acid yield: 0.075 g (yield 21.8%)
Point: 120 to 122°C 1H-NMR (CD3 OD): δ7.85 (2H
, d, J=7.1Hz, aromatic-H), 7.
55 (1H, t, J=7.2Hz, aromatic-
H) ,7.46(2H,t,J=7.3Hz,aro
matic-H), 4.26 (2H,s,H-5)
,2.80(3H,t,J=6.3Hz,H-3),2
.. 61 (2H, t, J=6.4Hz, H-2).
【0041】ここで得られた5−ベンゾイルアミドペン
タン−4−オリドは、実施例1の工程(C)と同様にし
て更に酸化することによって、5−ベンゾイルアミドレ
ブリン酸に変換した。The 5-benzoylamide pentane-4-olide obtained here was further oxidized in the same manner as in step (C) of Example 1, thereby converting it into 5-benzoylamide levulinic acid.
【0042】
(C)5−アミノレブリン酸塩酸塩の製造5−ベンゾイ
ルアミドレブリン酸 0.874g (3.72mmo
l)を6N塩酸水溶液10mlに懸濁し、7時間加熱還
流した。
反応が終了した後、周囲温度まで冷却し、析出した結晶
を濾別した。次いで、この濾液中の溶媒を減圧下で留去
した。得られた残留物を10重量%含水エタノールより
再結晶することにより5−アミノレブリン酸塩酸塩を得
た。(C) Production of 5-aminolevulinic acid hydrochloride 5-benzoylamide levulinic acid 0.874 g (3.72 mmo
1) was suspended in 10 ml of 6N aqueous hydrochloric acid solution and heated under reflux for 7 hours. After the reaction was completed, it was cooled to ambient temperature and the precipitated crystals were filtered off. Then, the solvent in this filtrate was distilled off under reduced pressure. The obtained residue was recrystallized from 10% by weight aqueous ethanol to obtain 5-aminolevulinic acid hydrochloride.
【0043】
5−アミノレブリン酸塩酸塩
収 量: 0.390g(収率 62.5 %) 1
H−NMR(D2 O):δ4.07(s,H−5),
2.84(t,J=6.3Hz,H−3),2.66(
t,J=6.2Hz,H−2) 。5-aminolevulinic acid hydrochloride yield: 0.390 g (yield 62.5%) 1
H-NMR (D2O): δ4.07 (s, H-5),
2.84(t, J=6.3Hz, H-3), 2.66(
t, J=6.2Hz, H-2).
【0044】[0044]
【発明の効果】本発明のδ−アミノレブリン酸の酸付加
塩の製造方法によれば、入手し易くかつ安価なテトラヒ
ドロフルフリルアミンを原料として、有害廃棄物を殆ど
生じない方法でしかも製造工程も煩雑ではなく、高収率
でδ−アミノレブリン酸の酸付加塩を得ることができる
。この結果、δ−アミノレブリン酸の酸付加塩を、安価
にかつ工業的に生産できる等効果を奏する。Effects of the Invention According to the method for producing acid addition salts of δ-aminolevulinic acid of the present invention, the method uses readily available and inexpensive tetrahydrofurfurylamine as a raw material, generates almost no hazardous waste, and the production process is complicated. Instead, the acid addition salt of δ-aminolevulinic acid can be obtained in high yield. As a result, the acid addition salt of δ-aminolevulinic acid can be industrially produced at low cost.
Claims (1)
ように、一般式(IV)で示されるテトラヒドロフルフ
リルアミン(IV)のアミノ基に該アミノ基を保護する
保護基を導入して一般式(III) で示される化合物
(III) を得る工程と、得られた化合物(III)
の1位及び4位の炭素を酸化することにより一般式(
II)で示される化合物(II)を得る工程と、得られ
た化合物(II)の保護基を酸で脱保護する工程とを具
備することを特徴とする一般式(I)で示されるδ−ア
ミノレブリン酸の酸付加塩の製造方法。 【化1】 (式中、R,R′は、一般的なアミノ基の保護基または
水素原子であり、少なくとも一方は一般的なアミノ基の
保護基である。また、R,R′の両方が前記保護基であ
る場合に、R,R′は互いに結合して環状になっていて
もよい。また、式中Xは一価の有機酸根または無機酸根
である。)Claim 1: As shown in reaction formula (1) shown in Chemical Formula 1, a protecting group for protecting the amino group is introduced into the amino group of tetrahydrofurfurylamine (IV) shown by general formula (IV). A process for obtaining a compound (III) represented by general formula (III) and the obtained compound (III)
The general formula (
δ- represented by general formula (I), which comprises a step of obtaining compound (II) represented by II) and a step of deprotecting the protecting group of the obtained compound (II) with an acid. A method for producing an acid addition salt of aminolevulinic acid. [Formula 1] (wherein, R and R' are a general amino group-protecting group or a hydrogen atom, and at least one is a general amino group-protecting group. Also, both R and R' is the above-mentioned protecting group, R and R' may be bonded to each other to form a ring. In the formula, X is a monovalent organic acid group or an inorganic acid group.)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91118328A EP0483714B1 (en) | 1990-10-29 | 1991-10-28 | A method of preparing an acid additional salt of delta-aminolevulinic acid |
DE69109444T DE69109444T2 (en) | 1990-10-29 | 1991-10-28 | A method of making an acid supplemental salt of delta aminolevulinic acid. |
US08/073,613 US5284973A (en) | 1990-10-29 | 1993-06-08 | Method of preparing an acid additional salt of delta-aminolevulinic acid |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP28848190 | 1990-10-29 | ||
JP2-288481 | 1990-10-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04217650A true JPH04217650A (en) | 1992-08-07 |
Family
ID=17730769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3022372A Pending JPH04217650A (en) | 1990-10-29 | 1991-02-15 | Production of acid addition salt of delta-amino-levulinic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04217650A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005314360A (en) * | 2004-03-30 | 2005-11-10 | Cosmo Oil Co Ltd | 5-aminolevulinic acid sulfonate and its manufacturing method |
JP2007015937A (en) * | 2005-07-05 | 2007-01-25 | Cosmo Oil Co Ltd | 5-aminolevulinic acid ester phosphate, method for producing the same and use thereof |
JP2007015938A (en) * | 2005-07-05 | 2007-01-25 | Cosmo Oil Co Ltd | 5-aminolevulinic acid ester sulfonate, method for producing the same and use thereof |
WO2008020532A1 (en) * | 2006-08-15 | 2008-02-21 | Cosmo Oil Co., Ltd. | Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof |
US8173839B2 (en) | 2004-03-30 | 2012-05-08 | Cosmo Oil Co., Ltd | 5-aminolevulinic acid salt, process for producing the same and use thereof |
-
1991
- 1991-02-15 JP JP3022372A patent/JPH04217650A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005314360A (en) * | 2004-03-30 | 2005-11-10 | Cosmo Oil Co Ltd | 5-aminolevulinic acid sulfonate and its manufacturing method |
JP4719483B2 (en) * | 2004-03-30 | 2011-07-06 | コスモ石油株式会社 | Process for producing 5-aminolevulinic acid sulfonate |
US8173839B2 (en) | 2004-03-30 | 2012-05-08 | Cosmo Oil Co., Ltd | 5-aminolevulinic acid salt, process for producing the same and use thereof |
US8471061B2 (en) | 2004-03-30 | 2013-06-25 | Cosmo Oil Co., Ltd. | 5-aminolevulinic acid salt, process for producing the same and use thereof |
JP2007015937A (en) * | 2005-07-05 | 2007-01-25 | Cosmo Oil Co Ltd | 5-aminolevulinic acid ester phosphate, method for producing the same and use thereof |
JP2007015938A (en) * | 2005-07-05 | 2007-01-25 | Cosmo Oil Co Ltd | 5-aminolevulinic acid ester sulfonate, method for producing the same and use thereof |
WO2008020532A1 (en) * | 2006-08-15 | 2008-02-21 | Cosmo Oil Co., Ltd. | Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof |
JP2008044882A (en) * | 2006-08-15 | 2008-02-28 | Cosmo Oil Co Ltd | New crystal of 5-aminolevulinic acid phosphate and method for producing the same |
US8158821B2 (en) | 2006-08-15 | 2012-04-17 | Cosmo Oil Co., Ltd. | Crystal of 5-aminolevulinic acid phosphate and process for producing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5842878B2 (en) | 12-oxocholanic acid tosylhydrazone compound, its production method and use | |
US5284973A (en) | Method of preparing an acid additional salt of delta-aminolevulinic acid | |
JPH04217650A (en) | Production of acid addition salt of delta-amino-levulinic acid | |
JP3763598B2 (en) | Method for producing tranexamic acid | |
JP2575781B2 (en) | 2,3-diacyloxy-4-hydroxy-topenanal and method for producing the same | |
JPS6317077B2 (en) | ||
EP0483714B1 (en) | A method of preparing an acid additional salt of delta-aminolevulinic acid | |
JPH0228144A (en) | Production of stereospecific intermediate useful for synthesis of peptide derivative | |
JPH04364146A (en) | Method for manufacturing vitamin k4 and vitamin k4 diacetate | |
KR100296737B1 (en) | The Process of Aceclofenac | |
JP2782756B2 (en) | Tetrabromocyclopenta [b] benzofuran derivative and method for producing the same | |
JPS6287599A (en) | Production of oxime derivative of erythromycin | |
JP2716243B2 (en) | N-benzyl-3-hydroxysuccinamic acid and method for producing the same | |
BE858864A (en) | NEW ESTERS OF PHENYL- AND PYRIDINE-3-CARBOXYLIC ACIDS AND PROCESS FOR THEIR PREPARATION | |
JP4121044B2 (en) | Method for producing sialic acid derivative | |
JPH0124782B2 (en) | ||
JP2542843B2 (en) | Novel norbornane derivative and method for producing the same | |
JPH03176463A (en) | Pyrrolidinol derivative and its production | |
KR900007370B1 (en) | Process for the preparation of 2,4-dibromo-5-fluorobenroicacid | |
JP3847375B2 (en) | Method for producing 2-indanol derivative | |
JP3876079B2 (en) | Process for producing 1,24-dihydroxycholesterols | |
JP2833672B2 (en) | Method for producing β-ketonitrile | |
KR100390549B1 (en) | Method for manufacturing 3-halomethyl-3-cephem | |
JPH0812658A (en) | Production of sydnones | |
JPS582958B2 (en) | Novel pyridoxamine compound and method for producing the same |